Labetuzumab

Item number	Size	Manual	Delivery time	Price
TGM-T9901A-004-1mg	1 mg	-	7 - 10 business days*	339.00€
TGM-T9901A-004-2mg	2 mg	-	7 - 10 business days*	466.00€
TGM-T9901A-004-5mg	5 mg	-	7 - 10 business days*	681.00€
TGM-T9901A-004-10mg	10 mg	-	7 - 10 business days*	1,069.00€
TGM-T9901A-004-25mg	25 mg	-	7 - 10 business days*	1,628.00€
TGM-T9901A-004-50mg	50 mg	-	7 - 10 business days*	2,188.00€
TGM-T9901A-004-100mg	100 mg	-	7 - 10 business days*	2,895.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody... more

Close menu

Product information "Labetuzumab"

Description: Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).

Keywords:	IMMU-14, IMMU-100, hMN-14
Supplier:	TargetMol
Supplier-Nr:	T9901A-004

Properties

Conjugate:

Database Information

KEGG ID :	K06499 \| Matching products
UniProt ID :	P06731 \| Matching products
Gene ID :	GeneID 1048 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Labetuzumab"

Write a review